Australia markets close in 32 minutes

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.71-0.68 (-2.91%)
At close: 04:00PM EDT
22.77 +0.06 (+0.26%)
After hours: 04:13PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
188,893
34,863
15,142
90,095
-
Other short-term investments
150,384
20,848
77,986
56,178
-
Total cash
339,277
55,711
93,128
146,273
-
Other current assets
2,251
6,172
4,948
-
-
Total current assets
341,528
62,258
98,891
149,789
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
0
10,794
11,157
11,855
-
Accumulated depreciation
0
-4,144
-2,802
-1,983
-
Net property, plant and equipment
0
6,650
8,355
9,872
-
Other long-term assets
331
2,236
2,680
1,957
-
Total non-current assets
331
8,886
11,035
11,829
-
Total assets
341,859
71,144
109,926
161,618
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
896
677
3,319
2,254
-
Accrued liabilities
8,566
7,918
9,042
9,694
-
Deferred revenues
0
517
2,359
0
-
Other current liabilities
1,878
330
783
464
-
Total current liabilities
31,978
14,656
20,144
16,443
-
Non-current liabilities
Deferred revenues
0
2,179
1,217
0
-
Other long-term liabilities
41,310
-
-
214
31
Total non-current liabilities
125,865
6,183
5,841
5,343
-
Total liabilities
157,843
20,839
25,985
21,786
-
Stockholders' equity
Common stock
184,937
6
5
5
-
Retained earnings
-764,414
-425,624
-341,809
-276,008
-
Accumulated other comprehensive income
302
-48
-20
11
-
Total stockholders' equity
184,016
50,305
83,941
139,832
-
Total liabilities and stockholders' equity
341,859
71,144
109,926
161,618
-